|
Epigenetic therapy agents |
| DNA methylation inhibitors |
| deoxycytidine analogs: 5-azacytidine, 5-aza-2-deoxycytidine, 1-β-D-arabinofuranosil 5-azacytosine, dihydro- 5-azacytidine |
| nucleic acid-based: MG98 antisense oligonucleotide |
| cytidine deaminase analogs: zebularine |
| non-nucleoside analogs: (-)-epigallocatechin-3-gallate, procaine, procainamide, hydralazine |
| Histone deacetylase inhibitors |
| Small molecular weight carboxilates: sodium butyrate, valproic acid, sodium phenylbutyrate and pivaloyloxymethyl butyrate |
| Hydroxamic acids: SAHA, trichostatin A, SBHA |
| Benzamides: CI-994, MS-275 |
| Epoxyketones: trapoxin B, 2-amino-8-oxo-9,10-epoxydecanoic acid |
| Cyclic peptides: apicidin, depsipeptide |
| Hybrid molecules: CHAP 31, CHAP50 |
Dueñas-González et al. Molecular Cancer 2005 4:38 doi:10.1186/1476-4598-4-38 |